|
Volumn 540, Issue 7633, 2016, Pages 344-345
|
Pharmacology: Inside-out receptor inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACID;
BMS 681;
CHEMOKINE RECEPTOR;
CHEMOKINE RECEPTOR CCR2;
CHEMOKINE RECEPTOR CCR2 ANTAGONIST;
CHEMOKINE RECEPTOR CCR9;
CHEMOKINE RECEPTOR CXCR4;
G PROTEIN COUPLED RECEPTOR;
MARAVIROC;
PLERIXAFOR;
RECEPTOR;
UNCLASSIFIED DRUG;
VERCIRNON;
BIOCHEMISTRY;
BIOTECHNOLOGY;
CANCER;
CELLS AND CELL COMPONENTS;
CHEMICAL BINDING;
DISEASE TREATMENT;
DRUG DEVELOPMENT;
IMMUNE SYSTEM;
INHIBITION;
PROTEIN;
ALLOSTERISM;
AUTOIMMUNE DISEASE;
CARBOXY TERMINAL SEQUENCE;
CELL SURFACE;
CRYSTAL STRUCTURE;
CRYSTALLIZATION;
CYTOPLASM;
DRUG ANTAGONISM;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG INHIBITION;
DRUG RECEPTOR BINDING;
DRUG TARGETING;
EXTRACELLULAR MATRIX;
HEMATOPOIETIC STEM CELL;
HUMAN;
INFLAMMATORY DISEASE;
LIGAND BINDING;
METASTASIS;
PHARMACOLOGY;
PRIORITY JOURNAL;
SHORT SURVEY;
HUMANS;
PHARMACOLOGY;
|
EID: 85016151723
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature20486 Document Type: Short Survey |
Times cited : (5)
|
References (12)
|